It’s no new news that Artificial Intelligence or AI is being used to further many advancements in various fields. One such area where AI is making waves is personal health and drug discovery. There are many companies that made headlines for employing AI to discover a breakthrough in medical sciences and you can now add another one to the list. The London-based AI startup Causaly has secured €4.3 million in Series A funding.
The new funding round for the startup was lead by Pentech Ventures and EBRD Venture Capital. Existing investors such as Marathon Venture Capital and angel investors also participated in the funding round.